Category: Clinical Trial
Clinical Trial market research reports by GlobalData
-
Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024
Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report pro ... Read More
-
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2024 provides an overview of Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top line data relating to the clinic ... Read More
-
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Global Clinical Trials Review, 2024 provides an overview of Methicillin-Resistant Staphyloc ... Read More
-
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2024 provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating t ... Read More
-
Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete
Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete Summary This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2024. Scope The clinical trials data used for these analyses were e ... Read More
-
Hyperinsulinemia (HI) - Competitive Landscape
Hyperinsulinemia (HI) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HI therapeutics. More than 1.07 billion prevalent cases of HI are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecas ... Read More
-
Acute Ischemic Stroke (AIS) - Competitive Landscape
Acute Ischemic Stroke (AIS) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AIS therapeutics. More than 90,000,000 diagnosed prevalent cases of AIS are anticipated in 2023 in the 16 countries covered in GlobalData’s epid ... Read More
-
Clinical Trials - Lessons from Trial Descriptors
Clinical Trials - Lessons from Trial Descriptors Summary This report provides an overview of various clinical trial descriptors captured in the GlobalData Pharma Intelligence Center until September 3, 2023. Scope This report provides a review of different clinical trial designs derived from the Glob ... Read More
-
Gout - Opportunity Assessment and Forecast
Gout - Opportunity Assessment and Forecast Summary The prevalence of gout is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 1.18%. Currently, the treatment regimen for gout in the 7MM is mostly limited to NSAIDs, corticosteroids, and ULTs with challenging safety ... Read More
-
Hepatitis B - Global Clinical Trials Review, 2023
Hepatitis B - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatitis B Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatitis B Clinical trials scenario. This report provides top line data ... Read More
-
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More
-
Gallbladder Cancer - Global Clinical Trials Review, 2023
Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More
-
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023
Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Chronic ... Read More
-
Hypertriglyceridemia - Global Clinical Trials Review, 2023
Hypertriglyceridemia - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hypertriglyceridemia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hypertriglyceridemia Clinical trials scenario. This rep ... Read More
-
Oral Mucositis - Global Clinical Trials Review, 2023
Oral Mucositis - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Oral Mucositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Oral Mucositis Clinical trials scenario. This report provides top l ... Read More
-
Hypothyroidism - Global Clinical Trials Review, 2023
Hypothyroidism - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hypothyroidism Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hypothyroidism Clinical trials scenario. This report provides top l ... Read More
-
Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2023
Idiopathic Inflammatory Myopathy (IIM) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Idiopathic Inflammatory Myopathy (IIM) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Idiopathic Inflamma ... Read More
-
Osteoporosis - Global Clinical Trials Review, 2023
Osteoporosis - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Osteoporosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Osteoporosis Clinical trials scenario. This report provides top line da ... Read More
-
Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Collagens Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path an ... Read More
-
Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Dev ... Read More
-
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countri ... Read More
-
Insomnia - Opportunity Assessment and Forecast
Insomnia - Opportunity Assessment and Forecast Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the insomnia market through 2032. Insomnia, currently represented in the International Classification of Sleep Disorders (Th ... Read More
-
Gaucher Disease - Opportunity Assessment and Forecast
Gaucher Disease - Opportunity Assessment and Forecast Summary The prevalence of GD is increasing at a steady rate, in line with population growth in the 7MM, at an AGR of 0.39%. Currently, the marketed treatment regimen for Type 1 GD and Type 3 GD is dominated by ERTs and SRTs (Cerezyme, VPRIV, Elel ... Read More
-
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Female Contraceptives market throu ... Read More
Research Assistance
